{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T06:42:28Z","timestamp":1772692948853,"version":"3.50.1"},"reference-count":42,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: MRI-based radiomics has shown promise in men with prostate cancer (PCa); however, successful clinical implementation is contingent upon on reproducible measurements. Purpose: We assessed the reproducibility of radiomics features extracted from bi-parametric prostate MRI (bpMRI) in prostate lesions and non-tumoral prostate tissue in men with PCa undergoing active surveillance (AS). Methods: This retrospective study included 47 men with biopsy-proven PCa undergoing AS (mean 68.9 \u00b1 8.2 years, mean PSA density [PSAD] 0.08 \u00b1 0.03 ng\/mL\/mL) who underwent two bpMRI approximately 12 months apart (range, 10\u201314 months; December 2018 to April 2020). The reproducibility of radiomics measurements was assessed using the same MRI platform (3T Skyra, Siemens Healthineers; inter-platform) (n = 37), different MRI vendors (Skyra, Siemens Healthineers; 3T Discovery MR750, GE Healthcare; inter-platform) (n = 10), and between observers (n = 10). Shape\/1st-\/2nd-order radiomics features were extracted from regions of interest on axial T2-weighted (T2-WI), diffusion-weighted imaging (DWI, b1600), and apparent diffusion coefficient (ADC) maps on prostate lesions, non-tumoral peripheral zones (PZs), and transition zones (TZs) using software. Reproducibility was evaluated by calculating the intraclass correlation coefficient (ICC) and coefficient of variation (CV). Associations of clinical variables and prostate volume were assessed. Results: PCa diagnoses included Gleason grade groups 1 (n = 46) and 2 (n = 1)]. Thirty-seven lesions (mean size 0.9 \u00b1 0.4 cm) in 31 patients had PI-RADS v2.1 scores of 2 (n = 3)\/3 (n = 12)\/4 (n = 21)\/5 (n = 1); 16 patients demonstrated diffuse PI-RADS 2 changes. Lesion radiomics features from T2-WI yielded a high proportion of good\/moderate ICCs (intra-platform, 77.8%; inter-platform, 56.5%), whereas most DWI\/ADC features yielded poor reproducibility. Similar results were observed for non-tumoral PZ\/TZ. Intra-platform CVs were lowest for T2-WI lesion features (13.6%) and background PZ\/TZ (&lt;13.3%), while DWI\/ADC exceeded 20%. Inter-platform CVs were lowest for lesions on T2-WI and were &lt;18% for DWI\/ADC; all background PZ\/TZ CVs were &lt; 16.4%. Inter-observer analyses showed good\/moderate ICCs across all sequences and regions (57.4\u201392.6%). The distribution of ICC and CV values did not differ between intra- and inter-platform analyses (p &gt; 0.05). Higher reproducibility (ICC &gt; 0.5) was associated with larger prostate volume (intra-platform diagnostic odds ratio [DOR] = 2.58, 95% confidence interval [95%CI], 1.35\u20133.80, p = 0.01; inter-platform DOR = 3.48, 95%CI 1.79\u20135.17, p = 0.01) and older age (inter-platform DOR = 5.30, 95%CI 3.75\u20136.85, p &lt; 0.01). Conclusions: Radiomics measurements from T2-WI demonstrated better intra-\/inter-platform reproducibility than DWI\/ADC for prostate lesions and non-tumoral tissue. Patient factors (larger prostate volumes and older age) influence radiomics stability. The optimization of diffusion-based radiomics features is needed to improve reproducibility given the essential role of DWI in prostate MRI.<\/jats:p>","DOI":"10.3390\/cancers18050778","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:18:45Z","timestamp":1772554725000},"page":"778","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reproducibility of MRI Radiomics Measurements in Men with Prostate Cancer Undergoing Active Surveillance"],"prefix":"10.3390","volume":"18","author":[{"given":"Himanshu","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7273-5415","authenticated-orcid":false,"given":"Haitham","family":"Al-Mubarak","sequence":"additional","affiliation":[{"name":"Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Lloret Del Hoyo","sequence":"additional","affiliation":[{"name":"Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4905-1151","authenticated-orcid":false,"given":"Ghadi","family":"Abboud","sequence":"additional","affiliation":[{"name":"Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Octavia","family":"Bane","sequence":"additional","affiliation":[{"name":"Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8212-7790","authenticated-orcid":false,"given":"Mickael","family":"Tordjman","sequence":"additional","affiliation":[{"name":"Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8729-9302","authenticated-orcid":false,"given":"Mira M.","family":"Liu","sequence":"additional","affiliation":[{"name":"Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8027-6661","authenticated-orcid":false,"given":"Vinayak","family":"Wagaskar","sequence":"additional","affiliation":[{"name":"The Department of Urology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashutosh","family":"Tewari","sequence":"additional","affiliation":[{"name":"The Department of Urology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bachir","family":"Taouli","sequence":"additional","affiliation":[{"name":"Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA"},{"name":"Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA"},{"name":"Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/cncr.32802","article-title":"Annual report to the nation on the status of cancer, part I: National cancer statistics","volume":"126","author":"Henley","year":"2020","journal-title":"Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41585-019-0212-4","article-title":"Multiparametric MRI for prostate cancer diagnosis: Current status and future directions","volume":"17","author":"Stabile","year":"2020","journal-title":"Nat. Rev. Urol."},{"key":"ref_3","first-page":"157","article-title":"Active surveillance in intermediate risk prostate cancer","volume":"72","author":"Chandrasekar","year":"2019","journal-title":"Arch. Esp. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.eururo.2018.06.008","article-title":"Active Surveillance for Low-risk Prostate Cancer: The European Association of Urology Position in 2018","volume":"74","author":"Briganti","year":"2018","journal-title":"Eur. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"199\u2013202; discussion 202\u2013193","DOI":"10.1016\/S0022-5347(01)65322-9","article-title":"Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate","volume":"157","author":"Eskew","year":"1997","journal-title":"J. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-5347(05)64051-7","article-title":"Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: Results of a community multi-practice study","volume":"169","author":"Presti","year":"2003","journal-title":"J. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0022-5347(05)67993-1","article-title":"A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy","volume":"163","author":"Babaian","year":"2000","journal-title":"J. Urol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/jmri.25372","article-title":"Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study","volume":"45","author":"Greer","year":"2017","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6940","DOI":"10.1007\/s00330-019-06166-z","article-title":"The primacy of multiparametric MRI in men with suspected prostate cancer","volume":"29","author":"Richenberg","year":"2019","journal-title":"Eur. Radiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): A paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00261-016-0848-y","article-title":"The utility of quantitative ADC values for differentiating high-risk from low-risk prostate cancer: A systematic review and meta-analysis","volume":"42","author":"Shaish","year":"2017","journal-title":"Abdom. Radiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur. Urol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","article-title":"Radiomics: Extracting more information from medical images using advanced feature analysis","volume":"48","author":"Lambin","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/JU.0000000000000272","article-title":"Radiomics Features Measured with Multiparametric Magnetic Resonance Imaging Predict Prostate Cancer Aggressiveness","volume":"202","author":"Hectors","year":"2019","journal-title":"J. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1118\/1.4918318","article-title":"Automated prostate cancer detection using T2-weighted and high-b-value diffusion-weighted magnetic resonance imaging","volume":"42","author":"Kwak","year":"2015","journal-title":"Med. Phys."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"024506","DOI":"10.1117\/1.JMI.4.2.024506","article-title":"Detection of prostate cancer in multiparametric MRI using random forest with instance weighting","volume":"4","author":"Lay","year":"2017","journal-title":"J. Med. Imaging"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/RLI.0000000000000788","article-title":"De Novo Radiomics Approach Using Image Augmentation and Features from T1 Mapping to Predict Gleason Scores in Prostate Cancer","volume":"56","author":"Makowski","year":"2021","journal-title":"Investig. Radiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"896.e1","DOI":"10.1016\/j.crad.2019.07.011","article-title":"Prediction of prostate cancer aggressiveness with a combination of radiomics and machine learning-based analysis of dynamic contrast-enhanced MRI","volume":"74","author":"Liu","year":"2019","journal-title":"Clin. Radiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/jmri.27138","article-title":"Radiomics Based on MRI as a Biomarker to Guide Therapy by Predicting Upgrading of Prostate Cancer From Biopsy to Radical Prostatectomy","volume":"52","author":"Zhang","year":"2020","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/jmri.26243","article-title":"Prostate Cancer Differentiation and Aggressiveness: Assessment with a Radiomic-Based Model vs. PI-RADS v2","volume":"49","author":"Chen","year":"2019","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1007\/s00330-017-4800-5","article-title":"Machine learning-based analysis of MR radiomics can help to improve the diagnostic performance of PI-RADS v2 in clinically relevant prostate cancer","volume":"27","author":"Wang","year":"2017","journal-title":"Eur. Radiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1007\/s00330-021-08282-1","article-title":"Precision of MRI radiomics features in the liver and hepatocellular carcinoma","volume":"32","author":"Carbonell","year":"2022","journal-title":"Eur. Radiol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ramli, Z., Karim, M.K.A., Effendy, N., Abd Rahman, M.A., Kechik, M.M.A., Ibahim, M.J., and Haniff, N.S.M. (2022). Stability and Reproducibility of Radiomic Features Based on Various Segmentation Techniques on Cervical Cancer DWI-MRI. Diagnostics, 12.","DOI":"10.3390\/diagnostics12123125"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clinimag.2022.01.002","article-title":"Repeatability, robustness, and reproducibility of texture features on 3 Tesla liver MRI","volume":"83","author":"Prabhu","year":"2022","journal-title":"Clin. Imaging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"044005","DOI":"10.1117\/1.JMI.9.4.044005","article-title":"Repeatability and reproducibility of magnetic resonance imaging-based radiomic features in rectal cancer","volume":"9","author":"Rai","year":"2022","journal-title":"J. Med. Imaging"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1038\/s41598-019-45766-z","article-title":"Repeatability of Multiparametric Prostate MRI Radiomics Features","volume":"9","author":"Schwier","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Lu, H., Parra, N.A., Qi, J., Gage, K., Li, Q., Fan, S., Feuerlein, S., Pow-Sang, J., Gillies, R., and Choi, J.W. (2020). Repeatability of Quantitative Imaging Features in Prostate Magnetic Resonance Imaging. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00551"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1148\/radiol.2015150244","article-title":"Clinical Intravoxel Incoherent Motion and Diffusion MR Imaging: Past, Present, and Future","volume":"278","author":"Iima","year":"2016","journal-title":"Radiology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00330-024-10890-6","article-title":"Diagnostic performance of ADC and ADCratio in MRI-based prostate cancer assessment: A systematic review and meta-analysis","volume":"35","author":"Agrotis","year":"2025","journal-title":"Eur. Radiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s00330-021-08251-8","article-title":"Sources of variation in multicenter rectal MRI data and their effect on radiomics feature reproducibility","volume":"32","author":"Schurink","year":"2022","journal-title":"Eur. Radiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.mri.2012.04.025","article-title":"Comparison of different mathematical models of diffusion-weighted prostate MR imaging","volume":"30","author":"Quentin","year":"2012","journal-title":"Magn. Reson. Imaging"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2020191145","article-title":"The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cmpb.2010.08.005","article-title":"Test-retest reliability and feature selection in physiological time series classification","volume":"105","author":"Gudmundsson","year":"2012","journal-title":"Comput. Methods Progr. Biomed."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1148\/radiol.2018172361","article-title":"Radiomics of CT Features May Be Nonreproducible and Redundant: Influence of CT Acquisition Parameters","volume":"288","author":"Berenguer","year":"2018","journal-title":"Radiology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/0962280214537333","article-title":"The emerging science of quantitative imaging biomarkers terminology and definitions for scientific studies and regulatory submissions","volume":"24","author":"Kessler","year":"2015","journal-title":"Stat. Methods Med. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1007\/s00330-020-07284-9","article-title":"How can we combat multicenter variability in MR radiomics? Validation of a correction procedure","volume":"31","author":"Orlhac","year":"2021","journal-title":"Eur. Radiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s13246-021-01022-1","article-title":"Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: Cross-vendor validation","volume":"44","author":"Ji","year":"2021","journal-title":"Phys. Eng. Sci. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/jmri.26933","article-title":"Histopathological Features of MRI-Invisible Regions of Prostate Cancer Lesions","volume":"51","author":"Ghobadi","year":"2020","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1007\/s00261-024-04212-z","article-title":"Characterization of renal masses with MRI-based radiomics: Assessment of inter-package and inter-observer reproducibility in a prospective pilot study","volume":"49","author":"Bane","year":"2024","journal-title":"Abdom. Radiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"E6265","DOI":"10.1073\/pnas.1505935112","article-title":"Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images","volume":"112","author":"Fehr","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1148\/radiol.13121454","article-title":"Quantitative analysis of multiparametric prostate MR images: Differentiation between prostate cancer and normal tissue and correlation with Gleason score--a computer-aided diagnosis development study","volume":"267","author":"Peng","year":"2013","journal-title":"Radiology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"024502","DOI":"10.1117\/1.JMI.6.2.024502","article-title":"Multisite evaluation of radiomic feature reproducibility and discriminability for identifying peripheral zone prostate tumors on MRI","volume":"6","author":"Chirra","year":"2019","journal-title":"J. Med. Imaging"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/5\/778\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:28:22Z","timestamp":1772688502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/5\/778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["cancers18050778"],"URL":"https:\/\/doi.org\/10.3390\/cancers18050778","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]}}}